Explore the detailed record of transactions filed by Peter Benson, Président du Conseil. Director active across 2 companies, notably Ascelia Pharma AB. Aggregated, 3 disclosures have been published. Activity tracked since 15 April 2025. The latest transaction was disclosed on 23 September 2025 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Peter Benson is the chairman of the board of Ascelia Pharma AB. He oversees the board's activities and plays a key role in defining the company's strategy. With extensive experience in the industry, Peter provides a strategic vision that guides Ascelia Pharma towards its growth objectives. His leadership is essential for ensuring effective governance and compliance with regulatory standards.